(VIANEWS) – Tilray (TLRY) registered an impressive 10.63% increase to EUR3.34 at 11:23 EST Monday morning. NASDAQ, where TLRY is listed, also saw its index rise 0.52%; this indicates a positive trend on Monday’s stock market. Tilray’s last closing price stood at EUR3.02 which was 41.02% lower than its 52-week high of EUR5.12.
About Tilray
Tilray Brands, Inc. is a global leader in the medical cannabis industry, engaged in research, cultivation, processing, distribution and sales of cannabis products. Operating through four segments–Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business–the company sells its range of products to retailers, wholesalers, patients physicians hospitals pharmacies researchers governments directly to consumers as well as through retailers wholesalers wholesalers wholesalers wholesalers wholesalers retailers wholesalers directly through brands as well as directly. Headquartered out of Leamington Canada–Tilray was previously known as Tilray Inc. before changing to Tilray Brands Inc. on January 1 2022–it had changed name officially into Tilray Brands Inc. on January 1.
Yearly Analysis
Based on the provided data, Tilray’s stock is currently underperforming its 52-week high but significantly above its 52-week low, suggesting potential for growth in the near future. Investors should exercise caution and carefully research company finances as well as market conditions before making investment decisions.
Tilray anticipates sales growth of 16.2% this year and 9.8% next year, which could potentially translate to increased profitability and stock price appreciation.
Tilray’s EBITDA of 2.85 may indicate that the company isn’t yet profitable and could face challenges in the near future, prompting investors to carefully consider this factor along with other financial metrics when assessing Tilray as an investment prospect.
Overall, Tilray stock may provide some investment potential, though investors should conduct thorough due diligence and carefully consider all risks and uncertainties before investing in any particular stock.
Technical Analysis
Moving AverageTilray’s current stock price has significantly outstripped both its 50-day moving average of EUR2.02 and 200-day moving average of EUR2.63, suggesting both short- and long-term bullishness in its shares.
VolumeThis morning’s trading volume of 29,526,027 shares is 6.32% higher than Tilray’s average daily trading volume of 27,769,500 shares – signalling increased buying pressure and possible bullish sentiment.
Volatility :Tilray has shown low volatility over the past week, month and quarter with intraday variation averages of 0.25%, 0.93% and 4.89%, respectively. However, its highest amplitude of average volatility was recorded as 2.44% over these time frames indicating potential price fluctuations in the near future.
Quarter Analysis
Tilray Inc. (TLRY), one of Canada’s premier cannabis companies, is enjoying impressive sales growth and revenue expansion. Tilray’s current quarter sales growth estimate stands at 13.6%; furthermore, projected quarter-by-quarter growth projections range between 61.5% and 54.5% indicating rapid expansion going forward.
Tilray reported year-on-year quarterly revenue growth for the twelve trailing months of 20.1%, an impressive increase over last year’s 15.8% figure. This increase can be attributed to growing cannabis product demand across both adult-use and medical markets – something likely to continue as more countries legalize cannabis and Tilray sees more revenue generated.
Investors seeking an investment with strong growth prospects in the cannabis industry may wish to consider Tilray as a possible candidate, though as with any financial decision it’s wise to conduct additional research and analysis before making a final decision.
Equity Analysis
Tilray currently has an EPS of EUR-2.38 for its trailing twelve month earnings per share (EPS), signalling to investors that it may not yet be profitable and providing insight into potential growth and returns for Tilray in future. This information should help them assess its growth potential.
Tilray’s return on equity (ROE) over the past twelve months stands at negative -37.14%, an indicator that indicates they are currently not making profits relative to shareholder equity and should serve as a warning sign to potential investors.
Overall, Tilray may not be an attractive investment option at present based on financial metrics alone; however, additional factors must be taken into consideration such as its growth potential, competitive landscape and industry trends before making a final investment decision.
More news about Tilray (TLRY).
